Pruritus
153
10
10
104
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
33 trials with published results (22%)
Research Maturity
104 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.5%
13 terminated out of 153 trials
88.9%
+2.4% vs benchmark
20%
31 trials in Phase 3/4
32%
33 of 104 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 104 completed trials
Clinical Trials (153)
Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population With Stable Mild Plaque Psoriasis, Dry Skin and Pruritus
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
Drug-induced Liver Injury: Itching Study
Assessing the Efficacy and Safety of Photobiomodulation for the Treatment of Pruritus
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Bioequivalence Study of Nalfurafine Hydrochloride Orally Disintegrating Tablets on Fasting and Fed in Humans
VR-PMR for Post-Burn Symptoms
Methotrexate Versus Apremilast for Pruritus in Psoriasis
Non Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations
Topical Acetaminophen for Itch Relief: a Proof of Concept Study in Healthy Subjects
Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus
Effect of Topically Applied Olive Oil on Pruritus in Hemodialysis Patients: Pretest-posttest Model With Control Group
TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis
Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch
Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus
Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis
Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
Acupuncture for Prevention of Itch in Caesarean Section
Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus
Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus